Pacific Biosciences of California PACB Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
Based on trailing twelve months.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's return on assets?
- Pacific Biosciences of California (PACB) reported return on assets of -15.6% in Q1 2026.
- How has Pacific Biosciences of California's return on assets changed year-over-year?
- Pacific Biosciences of California's return on assets increased by 70.0% year-over-year, from -52.2% to -15.6%.
- What is the long-term trend for Pacific Biosciences of California's return on assets?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's return on assets has grown at a 38.6% compound annual growth rate (CAGR), from 10.5% to -53.4%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.